logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Lincosamide Antibacterial class drugs

    FiltersReset Filters
    7 results
    • cleocin pediatric

      (clindamycin palmitate hydrochloride)
      Pharmacia & Upjohn Company LLC
      Usage: CLEOCIN PEDIATRIC (clindamycin palmitate HCl) is indicated for treating serious infections caused by susceptible anaerobic bacteria, streptococci, pneumococci, and staphylococci. It is reserved for penicillin-allergic patients or when penicillin is inappropriate, with caution due to the risk of colitis.
    • cleocin t

      (clindamycin phosphate)
      Pharmacia & Upjohn Company LLC
      Usage: CLEOCIN T Topical Solution, Gel, and Lotion are indicated for the treatment of acne vulgaris. Physicians should weigh the potential risks of diarrhea, bloody diarrhea, and pseudomembranous colitis when considering this medication.
    • clindagel

      (CLINDAMYCIN)
      Bausch Health US, LLC
      Usage: CLINDAGEL (clindamycin phosphate topical gel, 1%) is indicated for the treatment of mild to moderate acne vulgaris. Clinical studies demonstrate its effectiveness in reducing inflammatory and non-inflammatory lesions compared to a vehicle gel, with a notable reduction in total lesion counts over a 12-week period.
    • clindamycin phosphate

      (clindamycin phosphate)
      Greenstone LLC
      Usage: Clindamycin phosphate topical solution, gel, and lotion are indicated for the treatment of acne vulgaris. Physicians should evaluate the risk of gastrointestinal side effects, including diarrhea and pseudomembranous colitis, before prescribing.
    • clindamycin phosphate

      (Clindamycin Phosphate)
      Taro Pharmaceuticals U.S.A., Inc.
      Usage: Clindamycin phosphate gel USP, 1% is indicated for the treatment of acne vulgaris. Physicians should assess the risk of diarrhea and related complications when considering its use, as other agents may be more suitable.
    • clindamycin phosphate

      (Clindamycin Phosphate)
      Viona Pharmaceuticals Inc
      Usage: Clindamycin phosphate topical solution USP, 1% is indicated for the treatment of acne vulgaris. Caution is advised due to potential risks of diarrhea, bloody diarrhea, and pseudomembranous colitis, prompting consideration of alternative therapies.
    • clindesse

      (clindamycin phosphate)
      Padagis Israel Pharmaceuticals Ltd
      Usage: Clindesse is indicated for the treatment of bacterial vaginosis in non-pregnant women. This includes conditions formerly known as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis.